This age-related decline represents a meaningful gap in metabolic signaling that Ignite+ addresses directly.*
To investigate how antioxidants might affect cancer progression, Martin Berg, Ph.D., of the University of Gothenburg in Sweden, led a 2014 study in mouse models of human lung cancer
Glow GHK-Cu (50 mg) / BPC-157 (10 mg) / TB500 (10 mg)
A 2003 study by Staresinic, Sebecic, Patrlj, and colleagues in Journal of Orthopaedic Research used a rat Achilles tendon transection model with BPC-157 administered intraperitoneally once daily at 10 g/kg, 10 ng/kg, or 10 pg/kg and reported improved load-to-failure, Young's modulus of elasticity, and Achilles functional index scores, reduced tendon defect size by day 14, and increased tendocyte outgrowth in vitro with specific numerical effect sizes and p-values not reported in the abstract
Animal research provides valuable mechanistic understanding but doesn't guarantee identical effects or safety in humans
I think I met you in, what was it